PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL

F. Rivera; J. Tabernero; M. Galan; R. Lopez; B. Queralt; J. L. Garcia; J. E. Ales-Martinez; A. Anton; E. Aranda; J. Giralt

PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL

F. Rivera, J. Tabernero, M. Galan, R. Lopez, B. Queralt, J. L. Garcia, J. E. Ales-Martinez, A. Anton, E. Aranda, J. Giralt

Departament of Business

Research output: Contribution to journal › Article › Research › peer-review

Original language	Undefined/Unknown
Journal	Annals of Oncology
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Rivera, F., Tabernero, J., Galan, M., Lopez, R., Queralt, B., Garcia, J. L., Ales-Martinez, J. E., Anton, A., Aranda, E., & Giralt, J. (2010). PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL. Annals of Oncology.

@article{f441691c288d4145925dce5c91c5e45b,

title = "PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL",

author = "F. Rivera and J. Tabernero and M. Galan and R. Lopez and B. Queralt and Garcia, {J. L.} and Ales-Martinez, {J. E.} and A. Anton and E. Aranda and J. Giralt",

year = "2010",

language = "Indefinido/desconocido",

}

Rivera, F, Tabernero, J, Galan, M, Lopez, R, Queralt, B, Garcia, JL, Ales-Martinez, JE, Anton, A, Aranda, E & Giralt, J 2010, 'PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL', Annals of Oncology.

PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL. / Rivera, F.; Tabernero, J.; Galan, M. et al.

In: Annals of Oncology, 2010.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL

AU - Rivera, F.

AU - Tabernero, J.

AU - Galan, M.

AU - Lopez, R.

AU - Queralt, B.

AU - Garcia, J. L.

AU - Ales-Martinez, J. E.

AU - Anton, A.

AU - Aranda, E.

AU - Giralt, J.

PY - 2010

Y1 - 2010

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000284592300006&KeyUID=WOS:000284592300006

M3 - Artículo

ER -

Rivera F, Tabernero J, Galan M, Lopez R, Queralt B, Garcia JL et al. PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL. Annals of Oncology. 2010.

PHASE II STUDY OF INDUCTION TREATMENT (IT) OF CETUXIMAB (CET) WITH CHEMOTHERAPY (DOCETAXEL, CISPLATIN, 5FU-DCF-) FOLLOWED BY CET WITH CONCURRENT CHEMORADIOTHERAPY (CISPLATIN) IN PATIENTS (P) WITH LOCOREGIONAL OESOPHAGEAL CANCER (LROC). THE TTD-06-02/GICOR SPANISH COOPERATIVE GROUPS TRIAL

UN SDGs

Other files and links

Cite this